Ansa Biotechnologies at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Ansa Biotechnologies at ASHG 2026 in Montréal: Booth 1303.

Organization

ASHG 2026 Attendance

Ansa Biotechnologies

Emeryville

ansabio.com

Ansa sells enzymatic DNA synthesis products and custom gene synthesis services to life-science researchers.

Expanded IDT partnership broadens access to complex DNA (2026-09)

›

Expanded IDT partnership broadens access to complex DNA · 2026-09-01

“announced an expansion of their partnership to provide researchers worldwide broader access to Ansa’s Clonal DNA and XL Clonal DNA through IDT’s global e-commerce platform.”

Showcased 50 kb clonal DNA at SynBioBeta · 2026-04-29

“Direct, sequence-perfect clonal DNA up to 50 kb is empowering customers to expand their design space and innovate without compromise.”

Appointed Matthias Arenskötter chief operating officer · 2026-03-31

“Ansa Biotechnologies Inc. today announced the appointment of Matthias Arenskötter, PhD, as chief operating officer.”

Source: company newsroom

Raised $54.4M (Series B, 2025-09)

›

$54.4 million Series B; $45.2 million closed and $9.2 million additionally committed; led by Cerberus Ventures. · 2025-09

““closed $45.2 million and secured commitments for an additional $9.2 million”; “Series B round led by Cerberus Ventures.””

Source: funding announcement

Currently hiring: 6 open roles

›

Source: careers page

Booth

Exhibiting at Booth 1303

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Instantly find 20 buyers from Ansa Biotechnologies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction